Our study supports the hypothesis that the interplay between cadherins in breast cancer progression is not limited to the classical 'cadherin switch', which involves the loss of E-cadherin expression or function and the gain of N-cadherin, but comprises also an intricate interdependence of N-cadherin and VE-cadherin. The gene discussed is CDH2; the disease is breast carcinoma.